TBPH FY 2014 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

TBPHTheravance Biopharma, Inc.

$700M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+5071.7% YoY

Gross Profit

$8M65.3% margin

Operating Income

-$233M-1989.6% margin

Net Income

-$237M-2028.0% margin

EPS (Diluted)

$-7.46

Cash Flow

Operating Cash Flow

-$175M

Free Cash Flow

-$178M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$338M

Total Liabilities

$48M

Stockholders' Equity

$290M

Cash & Equivalents

$89M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$226,000	+5071.7%
Gross Profit	$8M	-$120M	+106.3%
Operating Income	-$233M	-$156M	-48.8%
Net Income	-$237M	-$156M	-51.7%